Charles Schwab Investment Management Inc Cue Biopharma, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$1.24 - $2.18 $92,329 - $162,320	-74,459 Reduced 81.35%	17,072 $21,000
Q1 2024 May 08, 2024	SELL	$1.77 - $3.09 $25,063 - $43,754	-14,160 Reduced 13.4%	91,531 $172,000
Q4 2023 Feb 06, 2024	BUY	$1.72 - $3.1 $16,530 - $29,794	9,611 Added 10.0%	105,691 $279,000
Q2 2023 Aug 09, 2023	BUY	$3.11 - $4.91 $217,687 - $343,680	69,996 Added 268.35%	96,080 $350,000
Q1 2023 May 11, 2023	BUY	$2.41 - $3.74 $32,371 - $50,235	13,432 Added 106.17%	26,084 $93,000
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $170,311 - $404,916	-68,398 Reduced 84.39%	12,652 $32,000
Q4 2021 Feb 11, 2022	BUY	$10.86 - $17.85 $30,625 - $50,337	2,820 Added 3.6%	81,050 $917,000
Q3 2021 Nov 16, 2021	SELL	$10.06 - $15.3 $1.22 Million - $1.86 Million	-121,330 Reduced 60.8%	78,230 $1.14 Million
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.53 $75,133 - $100,155	6,893 Added 3.58%	199,560 $2.33 Million
Q1 2021 May 17, 2021	BUY	$11.2 - $16.09 $92,355 - $132,678	8,246 Added 4.47%	192,667 $2.35 Million
Q4 2020 Feb 16, 2021	SELL	$11.12 - $16.4 $68,877 - $101,581	-6,194 Reduced 3.25%	184,421 $2.31 Million
Q3 2020 Nov 13, 2020	BUY	$15.05 - $23.54 $1.53 Million - $2.4 Million	101,956 Added 115.0%	190,615 $2.87 Million
Q2 2020 Aug 14, 2020	BUY	$12.7 - $30.73 $486,054 - $1.18 Million	38,272 Added 75.96%	88,659 $2.17 Million
Q1 2020 May 15, 2020	BUY	$9.85 - $22.27 $1,920 - $4,342	195 Added 0.39%	50,387 $715,000
Q4 2019 Feb 07, 2020	BUY	$7.06 - $17.47 $10,914 - $27,008	1,546 Added 3.18%	50,192 $797,000
Q3 2019 Nov 08, 2019	BUY	$6.78 - $9.28 $19,234 - $26,327	2,837 Added 6.19%	48,646 $411,000
Q1 2019 May 14, 2019	BUY	$4.7 - $9.29 $59,732 - $118,066	12,709 Added 38.4%	45,809 $355,000
Q2 2018 Aug 08, 2018	BUY	$10.93 - $14.48 $183,624 - $243,264	16,800 Added 103.07%	33,100 $393,000
Q1 2018 May 07, 2018	BUY	$11.63 - $17.25 $189,569 - $281,175	16,300 New	16,300 $230,000

Others Institutions Holding CUE

# of Institutions

Shares Held

14.1M

Call Options Held

14.4K

Put Options Held

2.6K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account